文献速递免疫规划

剂量反应研究十年后志愿者黄热病疫苗接种后免疫持续时间——一项补充研究

Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study - A complementary study.
PubMed 文献 · Vaccine · 2024-06-25

一项补充研究评估2009年Bio-Manguinhos/Fiocruz开展的17DD黄热病疫苗剂量反应研究受试者接种后10年的血清阳性率。

要点

  • 各疫苗组在血清阳性率和几何平均滴度评估上均显示相似性。
  • 这些发现进一步支持较低剂量黄热病疫苗的长期免疫原性。

核心结论

  • 接种后10年,六个递减剂量组在血清阳性率和几何平均滴度评估上均显示相似性。
  • 这些发现进一步支持较低剂量黄热病疫苗的长期免疫原性。

研究设计与样本

  • 递减剂量由生产商实验室稀释获得,试验批次经标准质量控制并按良好生产规范(GMP)生产。

主要发现

  • 接种后约30天,剂量低至587 IU的组免疫原性与全剂量相似,158 IU和31 IU组低于全剂量。
  • 血清阳性维持10个月,31 IU组除外。
  • 8年后随访评估的318名参与者中85%维持血清阳性,各组相似,减剂量组抗体滴度也与全剂量组相当。

关键数值与推荐

  • 接种后10年,10.447 IU组血清阳性率为90%。
  • 接种后10年,3.013 IU组血清阳性率为87%。
  • 接种后10年,587 IU组血清阳性率为93%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A single dose of standard yellow fever (YF) vaccine is considered to provide life-long protection. In this study, we evaluate the seropositivity conferred by lower doses 10 years post-vaccination. In 2009, Bio-Manguinhos/Fiocruz performed a dose-response study with the 17DD yellow fever vaccine, administering the vaccine in the usual mean dose of 27.476 IU and in decreasing doses (10.447 IU, 3.013 IU, 587 IU, 158 IU and 31 IU), with the usual volume and route (0,5 ml subcutaneous). The decreasing doses were obtained by dilution in the laboratory of the manufacturer and the lots in test had standard quality control and were produced by good manufacturing practices (GMP). Around 30 days after the vaccination, doses down to 587 IU had similar immunogenicity and the 158 IU and 31 IU were inferior to the full dose. The seropositivity was maintained for 10 months, except on the 31 IU group. Eight years after, 85 % of 318 participants evaluated in a follow-up, maintained seropositivity that was similar across groups. Consistently, antibody titers in the reduced-dose groups were also comparable to those of the full-dose group. The current study, 10 years later, showed similarity between the vaccine groups (six arms who received the YF vaccine in decreasing doses: 27.476 IU, 10.447 IU, 3.013 IU, 587 IU, 158 IU, 31 IU) both in relation of seropositivity and in the evaluation of the geometric mean titers. The seropositivity rates across subgroups were 83,1%, 90 %, 87 %, 93 %, 83,8% and 85 %, correspondingly. These findings provides further support to the long-term immunogenicity of lower doses. Clinical trial registry: NCT04416477.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Vianna CM, Noronha TG, Camacho LAB, et al. Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study - A complementary study. Vaccine. 2024. PMID: 38926068. doi:10.1016/j.vaccine.2024.06.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。